Blog
Schaffner Report: COVID-19 Vaccine Safety and Effectiveness
NFID Medical Director William Schaffner, MD, answers timely questions about the latest data on COVID-19 vaccine safety and effectiveness
What Have We Learned from COVID-19?
During World Immunization Week, NFID will host the virtual 2021 Annual Conference on Vaccinology Research (ACVR) on April 26-27, 2021, with presentations from leaders in the field of vaccinology, including three keynote lectures on the implications of the COVID-19 pandemic. Read more about the changes and challenges these renowned experts have seen throughout their remarkable careers …
Effective Communications: The “Secret Sauce” for COVID-19 Vaccination
The COVID-19 pandemic has confronted health communicators with unprecedented challenges. To achieve widespread “vaccine literacy,” health communicators must apply basic educational principles to promote trustworthy, straightforward communication …
ID News Round-Up: #COVID-19 Vaccination
A nationwide COVID-19 vaccination program is currently underway in the US. Where can you get vaccinated and when? What side effects can you expect? Will COVID-19 vaccines help end the pandemic? Read recent news of interest from the world of infectious diseases, with a focus on COVID-19 vaccination …
Recognizing #WomenInScience During Women’s History Month
Trailblazing women working in vaccinology will share stories about their individual paths and lessons learned throughout their careers at the 3rd Annual Women Leaders in Vaccinology Panel discussion during the 2021 Annual Conference on Vaccinology Research on April 26-27, 2021 …
Schaffner Report: New COVID-19 Vaccine and Other ACIP Updates
The Advisory Committee on Immunization Practices (ACIP) recently held two important meetings to review data on vaccines for influenza, hepatitis, pneumococcal disease, shingles, and other diseases, and to approve the new Janssen COVID-19 vaccine. Marla Dalton, executive director and CEO of the National Foundation for Infectious Diseases (NFID), talks with NFID Medical Director William Schaffner, MD, about the significance of these meetings for healthcare professionals and the public …
Black History Month: Vaccine Voices for COVID-19 Vaccine Choices
As we continue to tackle health equity issues, it is important to be open to embracing new partners and creating new champions. Although highlighting the contributions of Black scientists during Black History Month is important, addressing health equity can and should be done anytime and anywhere …
Getting Vaccinated Is Good for Your Heart
In honor of American Heart Month, NFID and the American Heart Association (AHA)—a proud supporter of the NFID Keep Up The Rates campaign—encourage individuals with chronic conditions to receive all of their recommended vaccines, despite delays that may have been caused by the COVID-19 pandemic …
Schaffner Report: COVID-19 Vaccines, Reinfection, and Masks
COVID-19 cases, hospitalizations, and deaths are starting to decline in the US, and vaccination rates are starting to increase. However, public health experts are concerned about new variants, the possibility of reinfection, and the overall risk of complacency. In this episode of the Schaffner Report, NFID Executive Director and CEO Marla Dalton, CAE, talks with NFID Medical Director William Schaffner, MD, about COVID-19 vaccines, masks, and reinfection …
Why Adults with Heart Disease Need an Annual Flu Vaccine
In the US, one in four deaths is caused by heart disease, making it one of the leading causes of death. To help raise awareness about the importance of heart-healthy lifestyles, including annual influenza (flu) vaccination, American Heart Month is observed each February …